About Neurotrack
Neurotrack is a company based in Redwood City (United States) founded in 2012 by Elli Kaplan. Neurotrack has raised $57.81 million across 12 funding rounds from investors including Khosla Ventures, Social Capital and Johnson & Johnson Innovative Medicine. Neurotrack offers products and services including Cognitive Assessment and Cognitive Screening Platform. Neurotrack operates in a competitive market with competitors including Tobii Dynavox, NovaSight, Artiria, C. Light Technologies and RetiSpec, among others.
- Headquarter Redwood City, United States
- Founders Elli Kaplan
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurotrack Technologies, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$57.81 M (USD)
in 12 rounds
-
Latest Funding Round
$10 M (USD), Series C
Nov 02, 2022
-
Investors
Khosla Ventures
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurotrack
Neurotrack offers a comprehensive portfolio of products and services, including Cognitive Assessment and Cognitive Screening Platform.
3-minute test for detecting cognitive impairment and dementia.
Platform integrating with EHR for early diagnosis of neurodegenerative conditions.
People of Neurotrack
Unlock access to complete
Unlock access to complete
Funding Insights of Neurotrack
Neurotrack has successfully raised a total of $57.81M across 12 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neurotrack
Neurotrack has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Khosla Ventures, Social Capital and Johnson & Johnson Innovative Medicine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Life sciences and tech focused impact VC firm funding companies in the US, the UK and Canada
|
Locked | Locked | Locked | |
|
AME Cloud Ventures is focused on investing in data-driven technology companies.
|
Locked | Locked | Locked |
Investor details for Neurotrack
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurotrack
Investment portfolio details for Neurotrack
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurotrack
Detailed financials for Neurotrack
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurotrack Comparisons
Peer comparison for Neurotrack
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurotrack
Neurotrack operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, NovaSight, Artiria, C. Light Technologies and RetiSpec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
|
|
| Locked | Locked | Locked |
Eye-tracking solutions for vision assessment and treatment are provided.
|
|
| Locked | Locked | Locked |
Micro-navigation systems for stroke surgery are developed.
|
|
| Locked | Locked | Locked |
Eye-tracking devices are developed for neurodegenerative disease monitoring.
|
|
| Locked | Locked | Locked |
Non-invasive eye scanner for early Alzheimer’s detection is developed.
|
|
| Locked | Locked | Locked |
Eye-tracking technology is utilized to detect traumatic brain injuries.
|
Detailed competitors of Neurotrack
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurotrack
Complete news archive for Neurotrack
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurotrack
Neurotrack was founded in 2012.
Neurotrack is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Elli Kaplan is the current CEO of Neurotrack. They have also founded this company.
Neurotrack is a funded company, having raised a total of $57.81M across 12 funding rounds to date.
The company was founded in 2012 in Redwood City, United States, within the healthcare technology sector. Clinical assessment tools are provided for diagnosing neurological disorders, incorporating the Imprint Memory Assessment. This proprietary method employs computer vision algorithms and eye-tracking technology to evaluate behavioral biomarkers during cognitive and visual tests. Partnerships with pharmaceutical firms and researchers are maintained to facilitate clinical trial recruitment, assess drug efficacy, and advance drug development processes.
Neurotrack's top competitors include NovaSight, RetiSpec and Tobii Dynavox.
Neurotrack offers Cognitive Assessment and Cognitive Screening Platform.
Neurotrack has 15 investors. Key investors include Khosla Ventures, Social Capital, Johnson & Johnson Innovative Medicine, Sompo Holdings, and HHS.